KMC Speciality Hospitals (India)524520Promoter pledge update

Revised encumbrance disclosures: pledge and non-disposal undertaking over holding-company shares

Revised Reg 31(1) and 31(2) disclosures shared 14th October, 2026, after BSE flagged two discrepancies on October 7, 2026; both shown as "Rectified".

By ScoutQuest · Wed 14 Oct 2026, 4:04 PM IST · 3 min read

52.3%Event holding of encumbered shares as share of SKMCIL fully diluted shareholding

Event holding of encumbered shares as share of SKMCIL fully diluted shareholding: 52.30%.

Pledge over SKMCIL shares: 74,10,831 shares = 14.53% of fully diluted shareholding
Non-disposal undertaking over SKMCIL shares: 1,65,32,316 shares = 32.40% of fully diluted shareholding
Post-event encumbered holding: 52.30% of SKMCIL's fully diluted shareholding

Two letters dated 14th October, 2026 sit behind this update. One is from KMC Speciality Hospitals (India) Ltd and explains what was corrected after BSE wrote to it on October 7, 2026. The other encloses the revised encumbrance disclosure given by Sri Kauvery Medical Care (India) Ltd, called SKMCIL in the update, signed by its Executive Chairman (Whole-Time).

What the exchange had flagged

Pre-event encumbered shareholdings in consecutive transactions remained unchanged and did not reconcile with the post-event holdings of the immediately preceding transactions.
Only the name of the trustee was given, and the lender's name was not provided, under the details of the entity in whose favour the shares are being encumbered.

Against both points, the covering letter records the revision as "Rectified".

Where the encumbrance sits

SKMCIL is the promoter of the Target Company and holds 75% of it.
The encumbrance disclosed is indirect. It arises solely by virtue of a pledge and a non-disposal undertaking over shares of SKMCIL, the holding company, and not by way of any direct pledge or other encumbrance over the shares of the Target Company.

Creation reported for August 04, 2026

A pledge over 74,10,831 equity shares of SKMCIL, aggregating to 14.53% of the fully diluted shareholding of SKMCIL.
A non-disposal undertaking over 1,65,32,316 equity shares of SKMCIL, aggregating to 32.40% of the fully diluted shareholding of SKMCIL.
Both are in favour of Catalyst Trusteeship Limited, the Debenture Trustee.
Reason: the shares of SKMCIL, the holding company, have been pledged or placed under a non-disposal undertaking by its promoter group as security for credit facility availed by them.
The pledge agreement was executed on July 07, 2026 and the non-disposal undertakings were provided on July 06, 2026. The creation of the entire encumbrance was completed on the depository system on August 04, 2026.

Creation reported for September 04, 2026

A pledge over 27,41,435 equity shares of SKMCIL, aggregating to 5.37% of the fully diluted shareholding of SKMCIL.
In whose favour: Catalyst Trusteeship Limited, the Debenture Trustee.
The creation was completed on the depository system on September 04, 2026, in relation to the debentures allotted by the Issuer.
After this creation, the post-event holding of encumbered shares stands at 52.30% of the fully diluted shareholding of SKMCIL.

The debentures in the background

Prospera Healthcorp Private Limited is the Issuer. It issued non-convertible debentures under a debenture trust deed dated July 6, 2026 with Catalyst Trusteeship Limited as the Debenture Trustee, pursuant to its board meeting held on 2nd July 2026.
Debenture holders as of August 04, 2026: Standard Chartered Bank and Jio Credit Limited.
Debenture holders as of September 4, 2026: Standard Chartered Bank, Jio Credit Limited, Nippon Life India Trustee Ltd and Kavita Goyal.

How to read it

The shares being encumbered belong to the promoter's holding company; the shares of KMC Speciality Hospitals (India) Ltd itself are not the ones under pledge or under a non-disposal undertaking, as the update clarifies.
The first creation accounted for 14.53% of SKMCIL's fully diluted shareholding by way of pledge, alongside 32.40% by way of non-disposal undertaking; the later creation added 5.37%, taking the reported encumbered holding to 52.30%.
This is a revision of disclosures already made: the company has corrected how the pre-event and post-event encumbered holdings reconcile, and has named the lender alongside the trustee.

52.30%Event holding of encumbered shares as share of SKMCIL fully diluted shareholding

Non-disposal undertaking as share of SKMCIL fully diluted shareholding32.40%

Pledge as share of SKMCIL fully diluted shareholding14.53%

Pledge as share of SKMCIL fully diluted shareholding (September 045.37%

Event holding of encumbered shares as share of SKMCIL fully diluted shareholding 52.30%: Non-disposal undertaking as share of SKMCIL fully diluted shareholding 32.40%, Pledge as share of SKMCIL fully diluted shareholding 14.53%, Pledge as share of SKMCIL fully diluted shareholding (September 04 5.37%.